ORGANON & CO (OGN) Stock Fundamental Analysis

NYSE:OGN • US68622V1061

7.29 USD
+0.06 (+0.83%)
At close: Feb 27, 2026
7.28 USD
-0.01 (-0.14%)
After Hours: 2/27/2026, 8:25:18 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall OGN gets a fundamental rating of 5 out of 10. We evaluated OGN against 192 industry peers in the Pharmaceuticals industry. While OGN belongs to the best of the industry regarding profitability, there are concerns on its financial health. OGN is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • OGN had positive earnings in the past year.
  • In the past year OGN had a positive cash flow from operations.
  • OGN had positive earnings in each of the past 5 years.
  • OGN had a positive operating cash flow in each of the past 5 years.
OGN Yearly Net Income VS EBIT VS OCF VS FCFOGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • OGN has a Return On Assets of 3.70%. This is amongst the best in the industry. OGN outperforms 84.90% of its industry peers.
  • OGN has a Return On Equity of 55.30%. This is amongst the best in the industry. OGN outperforms 98.96% of its industry peers.
  • OGN's Return On Invested Capital of 9.86% is amongst the best of the industry. OGN outperforms 89.58% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for OGN is in line with the industry average of 12.96%.
Industry RankSector Rank
ROA 3.7%
ROE 55.3%
ROIC 9.86%
ROA(3y)7.82%
ROA(5y)11.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.92%
ROIC(5y)16.57%
OGN Yearly ROA, ROE, ROICOGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • OGN has a better Profit Margin (7.95%) than 83.33% of its industry peers.
  • In the last couple of years the Profit Margin of OGN has declined.
  • With an excellent Operating Margin value of 21.54%, OGN belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
  • OGN's Operating Margin has declined in the last couple of years.
  • OGN has a Gross Margin of 55.04%. This is in the better half of the industry: OGN outperforms 68.23% of its industry peers.
  • In the last couple of years the Gross Margin of OGN has declined.
Industry RankSector Rank
OM 21.54%
PM (TTM) 7.95%
GM 55.04%
OM growth 3Y-8.47%
OM growth 5Y-14.29%
PM growth 3Y-14.29%
PM growth 5Y-20.08%
GM growth 3Y-2.36%
GM growth 5Y-3.89%
OGN Yearly Profit, Operating, Gross MarginsOGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so OGN is creating value.
  • Compared to 1 year ago, OGN has more shares outstanding
  • OGN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for OGN has been reduced compared to a year ago.
OGN Yearly Shares OutstandingOGN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
OGN Yearly Total Debt VS Total AssetsOGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • OGN has an Altman-Z score of 1.20. This is a bad value and indicates that OGN is not financially healthy and even has some risk of bankruptcy.
  • OGN has a Altman-Z score (1.20) which is in line with its industry peers.
  • OGN has a debt to FCF ratio of 15.60. This is a negative value and a sign of low solvency as OGN would need 15.60 years to pay back of all of its debts.
  • OGN's Debt to FCF ratio of 15.60 is fine compared to the rest of the industry. OGN outperforms 77.08% of its industry peers.
  • OGN has a Debt/Equity ratio of 9.69. This is a high value indicating a heavy dependency on external financing.
  • OGN's Debt to Equity ratio of 9.69 is on the low side compared to the rest of the industry. OGN is outperformed by 82.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 9.69
Debt/FCF 15.6
Altman-Z 1.2
ROIC/WACC1.56
WACC6.34%
OGN Yearly LT Debt VS Equity VS FCFOGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.75 indicates that OGN should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.75, OGN is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.20 indicates that OGN should not have too much problems paying its short term obligations.
  • OGN has a Quick ratio of 1.20. This is in the lower half of the industry: OGN underperforms 72.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.2
OGN Yearly Current Assets VS Current LiabilitesOGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for OGN have decreased strongly by -10.95% in the last year.
  • The earnings per share for OGN have been decreasing by -10.06% on average. This is quite bad
EPS 1Y (TTM)-10.95%
EPS 3Y-10.06%
EPS 5YN/A
EPS Q2Q%-30%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.34%

3.2 Future

  • Based on estimates for the next years, OGN will show a small growth in Earnings Per Share. The EPS will grow by 1.74% on average per year.
  • The Revenue is expected to grow by 0.43% on average over the next years.
EPS Next Y5.85%
EPS Next 2Y5.13%
EPS Next 3Y5.79%
EPS Next 5Y1.74%
Revenue Next Year-1.78%
Revenue Next 2Y-0.08%
Revenue Next 3Y0.62%
Revenue Next 5Y0.43%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
OGN Yearly Revenue VS EstimatesOGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
OGN Yearly EPS VS EstimatesOGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 1.99 indicates a rather cheap valuation of OGN.
  • Compared to the rest of the industry, the Price/Earnings ratio of OGN indicates a rather cheap valuation: OGN is cheaper than 98.96% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, OGN is valued rather cheaply.
  • OGN is valuated cheaply with a Price/Forward Earnings ratio of 1.88.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of OGN indicates a rather cheap valuation: OGN is cheaper than 98.44% of the companies listed in the same industry.
  • OGN is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 1.99
Fwd PE 1.88
OGN Price Earnings VS Forward Price EarningsOGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 96.88% of the companies in the same industry are more expensive than OGN, based on the Enterprise Value to EBITDA ratio.
  • 98.44% of the companies in the same industry are more expensive than OGN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.35
EV/EBITDA 5.91
OGN Per share dataOGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • OGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y5.13%
EPS Next 3Y5.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • OGN has a Yearly Dividend Yield of 1.11%. Purely for dividend investing, there may be better candidates out there.
  • OGN's Dividend Yield is rather good when compared to the industry average which is at 1.07. OGN pays more dividend than 90.63% of the companies in the same industry.
  • OGN's Dividend Yield is slightly below the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

  • OGN has been paying a dividend for over 5 years, so it has already some track record.
  • OGN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
OGN Yearly Dividends per shareOGN Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • OGN pays out 31.54% of its income as dividend. This is a sustainable payout ratio.
DP31.54%
EPS Next 2Y5.13%
EPS Next 3Y5.79%
OGN Yearly Income VS Free CF VS DividendOGN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
OGN Dividend Payout.OGN Dividend Payout, showing the Payout Ratio.OGN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ORGANON & CO

NYSE:OGN (2/27/2026, 8:25:18 PM)

After market: 7.28 -0.01 (-0.14%)

7.29

+0.06 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners79.58%
Inst Owner Change-1.32%
Ins Owners0.36%
Ins Owner Change1.29%
Market Cap1.90B
Revenue(TTM)N/A
Net Income(TTM)501.00M
Analysts48.75
Price Target9.18 (25.93%)
Short Float %5.56%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP31.54%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-23
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.63%
Min EPS beat(2)4.46%
Max EPS beat(2)6.8%
EPS beat(4)4
Avg EPS beat(4)6.63%
Min EPS beat(4)2.83%
Max EPS beat(4)12.44%
EPS beat(8)7
Avg EPS beat(8)6.8%
EPS beat(12)8
Avg EPS beat(12)3.85%
EPS beat(16)12
Avg EPS beat(16)6.75%
Revenue beat(2)2
Avg Revenue beat(2)1.21%
Min Revenue beat(2)0.69%
Max Revenue beat(2)1.72%
Revenue beat(4)2
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.12%
Max Revenue beat(4)1.72%
Revenue beat(8)5
Avg Revenue beat(8)0.37%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.1%
PT rev (1m)0%
PT rev (3m)-3.2%
EPS NQ rev (1m)-3.67%
EPS NQ rev (3m)-4.62%
EPS NY rev (1m)-0.53%
EPS NY rev (3m)-2.43%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.01%
Valuation
Industry RankSector Rank
PE 1.99
Fwd PE 1.88
P/S 0.3
P/FCF 3.35
P/OCF 2
P/B 2.09
P/tB N/A
EV/EBITDA 5.91
EPS(TTM)3.66
EY50.21%
EPS(NY)3.87
Fwd EY53.14%
FCF(TTM)2.18
FCFY29.86%
OCF(TTM)3.65
OCFY50.07%
SpS24.24
BVpS3.48
TBVpS-19.67
PEG (NY)0.34
PEG (5Y)N/A
Graham Number16.94
Profitability
Industry RankSector Rank
ROA 3.7%
ROE 55.3%
ROCE 12.48%
ROIC 9.86%
ROICexc 10.51%
ROICexgc 25.64%
OM 21.54%
PM (TTM) 7.95%
GM 55.04%
FCFM 8.98%
ROA(3y)7.82%
ROA(5y)11.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.92%
ROIC(5y)16.57%
ROICexc(3y)13.99%
ROICexc(5y)17.59%
ROICexgc(3y)39.55%
ROICexgc(5y)50.27%
ROCE(3y)16.36%
ROCE(5y)22.15%
ROICexgc growth 3Y-23.31%
ROICexgc growth 5Y-17.1%
ROICexc growth 3Y-16.16%
ROICexc growth 5Y-19%
OM growth 3Y-8.47%
OM growth 5Y-14.29%
PM growth 3Y-14.29%
PM growth 5Y-20.08%
GM growth 3Y-2.36%
GM growth 5Y-3.89%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 9.69
Debt/FCF 15.6
Debt/EBITDA 5.17
Cap/Depr 111.99%
Cap/Sales 6.08%
Interest Coverage 250
Cash Conversion 55.86%
Profit Quality 112.97%
Current Ratio 1.75
Quick Ratio 1.2
Altman-Z 1.2
F-Score5
WACC6.34%
ROIC/WACC1.56
Cap/Depr(3y)126.74%
Cap/Depr(5y)142.32%
Cap/Sales(3y)4.85%
Cap/Sales(5y)4.63%
Profit Quality(3y)60.39%
Profit Quality(5y)86.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.95%
EPS 3Y-10.06%
EPS 5YN/A
EPS Q2Q%-30%
EPS Next Y5.85%
EPS Next 2Y5.13%
EPS Next 3Y5.79%
EPS Next 5Y1.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.34%
Revenue Next Year-1.78%
Revenue Next 2Y-0.08%
Revenue Next 3Y0.62%
Revenue Next 5Y0.43%
EBIT growth 1Y-8.87%
EBIT growth 3Y-7.99%
EBIT growth 5Y-17.56%
EBIT Next Year8.93%
EBIT Next 3Y3.53%
EBIT Next 5Y3.63%
FCF growth 1Y33.49%
FCF growth 3Y-35.21%
FCF growth 5Y-26.14%
OCF growth 1Y41.85%
OCF growth 3Y-27.44%
OCF growth 5Y-19.44%

ORGANON & CO / OGN FAQ

Can you provide the ChartMill fundamental rating for ORGANON & CO?

ChartMill assigns a fundamental rating of 5 / 10 to OGN.


What is the valuation status of ORGANON & CO (OGN) stock?

ChartMill assigns a valuation rating of 9 / 10 to ORGANON & CO (OGN). This can be considered as Undervalued.


What is the profitability of OGN stock?

ORGANON & CO (OGN) has a profitability rating of 6 / 10.


What is the valuation of ORGANON & CO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ORGANON & CO (OGN) is 1.99 and the Price/Book (PB) ratio is 2.09.


What is the expected EPS growth for ORGANON & CO (OGN) stock?

The Earnings per Share (EPS) of ORGANON & CO (OGN) is expected to grow by 5.85% in the next year.